Concepedia

David Bermudes

DB

Statistics

Publications

48

Citations

4.4K

H-Index

30

Active since

1985

Affiliations

Vion Pharmaceuticals (United States)(Current)

Yale University

University of Wisconsin–Milwaukee

Celator Pharmaceuticals (Canada)

Boston University

David Bermudes is an author at Vion Pharmaceuticals (United States) specializing in life sciences, microbiology, and medicine.

Publications per year

1985–2016

48

Publications

48

Tumor-targeted Salmonella as a novel anticancer vector.

John M. Pawelek, K. Brooks Low, David Bermudes · PubMed · 1997 · 527 citations

Medicine, Biotechnology, Oncology +12

Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo

K. Brooks Low, Martina Ittensohn, Trung Bao Le et al. · Nature Biotechnology · 1999 · 476 citations

Life Sciences, Immunology, Microbiology +12

In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy

Paul Tardi, Sharon A. Johnstone, Natashia Harasym et al. · Leukemia Research · 2008 · 354 citations

Medicine, Pharmacokinetics, Pharmacology +8

Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of<i>Salmonella typhimurium</i>

Caroline Clairmont, K. C. Lee, Jeremy A. Pike et al. · The Journal of Infectious Diseases · 2000 · 350 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

Kinetics and pattern of organelle exocytosis duringToxoplasma gondii/host-cell interaction

Jean Fran�ois Dubremetz, Abderrahim Achbarou, David Bermudes et al. · Parasitology Research · 1993 · 191 citations

Life Sciences, Cell Biology, Molecular Biology +14

1–5 of 48